Lyell Immunopharma, Inc. (LYEL) is trading at $13.70 down 4.40% over the past 24 hours. Its Galaxy Score is 49.0, LunarCrush's combined measure of market and social performance. Over the last 24 hours it has seen 228 engagements and 13 posts with 100% positive social sentiment.
AI summary: Lyell Immunopharma, Inc. is a cancer immunotherapy biotech company trading as LYEL. Bullish social momentum suggests a potential rally, but price confirmation is needed; a breakout above near-term resistance could spark upside moves if chatter remains strong.
Lyell Immunopharma, Inc. (LYEL) is tracked on LunarCrush, where you can follow its price alongside live social activity and sentiment across X, Reddit, YouTube and other networks.
Lyell Immunopharma, Inc. (LYEL) is trading at $13.70, down 4.40% over the past 24 hours.
$LYEL has a Galaxy Score of 49.0 — LunarCrush's 0–100 measure combining an asset's market and social performance.
Yes. $LYEL social sentiment is 100% positive across social posts over the last 24 hours.
There have been 13 posts about $LYEL over the last 24 hours.
On LunarCrush — follow $LYEL's real-time social sentiment, engagement and market activity across X, Reddit, YouTube, TikTok and news in one place.